Table: Cosmos Pharmaceutical -Q1 group results

Cosmos Pharmaceutical

12/10/2020 07:00

Oct 12 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2020        Aug 31, 2019     May 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            189.16              164.50           723.00    
                 (+15.0 pct)         (+7.1 pct)       (+5.6 pct)  
  Operating         10.66                7.02            29.10    
                 (+51.7 pct)         (+0.4 pct)       (+0.0 pct)  
  Recurring         11.22                7.53            31.60    
                 (+49.0 pct)         (-0.3 pct)       (+0.1 pct)  
  Net                7.49                5.05            21.78    
                 (+48.3 pct)         (+3.4 pct)       (+1.6 pct)  
  EPS            189.15 yen          127.53 yen       550.01 yen  
  Ann Div                            110.00 yen        55.00 yen  
  -Q2 div                             50.00 yen        27.50 yen  
  -Q4 div                             60.00 yen        27.50 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T